UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033544
Receipt number R000038250
Scientific Title Relationship between carcinogenesis of esophageal squamous cell carcinoma and esophageal microbiota
Date of disclosure of the study information 2018/07/30
Last modified on 2020/07/28 17:34:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between carcinogenesis of esophageal squamous cell carcinoma and esophageal microbiota

Acronym

Relationship between carcinogenesis of esophageal squamous cell carcinoma and esophageal microbiota

Scientific Title

Relationship between carcinogenesis of esophageal squamous cell carcinoma and esophageal microbiota

Scientific Title:Acronym

Relationship between carcinogenesis of esophageal squamous cell carcinoma and esophageal microbiota

Region

Japan


Condition

Condition

Esophageal squamous cell carcinoma and achalasia

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to elucidate the relationship between carcinogenesis of esophageal squamous cell carcinoma and esophageal microbiota in patients with achalasia and esophageal squamous cell carcinoma.

Basic objectives2

Others

Basic objectives -Others

Esophageal microbiota before and after per-oral endoscopic myotomy in patients with achalasia.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The effect of esophageal microbiota on carcinogenesis of esophageal squamous cell carcinoma in patients with achalasia

Key secondary outcomes

Esophageal microbiota before and after per-oral endoscopic myotomy in patients with achalasia.
Comparison of esophageal microbiota between the patients with esophageal squamous cell carcinoma and the patients with achalasia


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

1. The patient who is older than 18 when the informed consent is obtained.
2. The patient who is diagnosed with achalasia or esophageal squamous cell carcinoma and is going to undergo endoscopic treatment in our hospital.
3. The performance status of the patients is 0, 1, or 2.
4. The patient whose informed consent is obtained.

Key exclusion criteria

1. The patient who is pregnant or performing breast feeding.
2. The patient who was registered in this study before.
3. The patient who has risks for bleeding after esophageal biopsy.
4. The patient who underwent gastrectomy before.
5. The patient who had past histories of cervical cancer or esophageal cancer treated by radiation.
6. The patient who are being treated for cancers in other organs
7. The patients who are judged by the investigators to be inappropriate participants in the trial.




Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shuji Terai

Organization

Graduate School of Medical and Dental Sciences, Niigata University

Division name

Division of Gastroenterology and Hepatology

Zip code


Address

757-1, Asahimachidori, Chuo-ku, Niigata-city, Niigata 951-8510, Japan

TEL

025-227-2207

Email

terais@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuya Takahashi

Organization

Graduate School of Medical and Dental Sciences, Niigata University

Division name

Division of Gastroenterology and Hepatology

Zip code


Address

757-1, Asahimachidori, Chuo-ku, Niigata-city, Niigata 951-8510, Japan

TEL

025-227-2207

Homepage URL


Email

kazuya911@med.niigata-u.ac.jp


Sponsor or person

Institute

Graduate School of Medical and Dental Sciences, Niigata University

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

新潟大学医歯学総合病院


Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 06 Month 30 Day

Date of IRB

2018 Year 06 Month 18 Day

Anticipated trial start date

2018 Year 07 Month 30 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, we obtain esophageal specimens using a brush for biliary cytology via endoscopic forceps channel. we are going to perform 16S rRNA gene amplicon sequencing analysis in 5 patients with esophageal squamous cell carcinoma before endoscopic submucosal dissection and 15 patients with achalasia before and after per-oral endoscopic myotomy. We also investigate the relationship between inflammation of the esophageal epithelium and esophageal microbiota in these patients.


Management information

Registered date

2018 Year 07 Month 27 Day

Last modified on

2020 Year 07 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038250